New Approaches to navigate Complexities in Drug Discovery and Development In collaboration with Faculty of Pharmacy, Ramaiah University of Applied Sciences, Bengaluru
Early Registration Closes
Tuesday, 10th February 2026
20th - 22nd February, 2026
Join the conversation across these specialized tracks:
The conference will feature
led by global experts in ADMET (Absorption, Distribution. Metabolism. Excretion. and Toxicity) and CMC (Chemistry. Manufacturing, and Controls).
SSX-India invites abstracts for its 9th Annual conference on a theme "New Approaches for Navigating Complexities in Drug Discovery and Development". Participants are suggested to submit their abstracts from the following domains.
Presenting Author/Speaker:Please provide all required information for yourself as the presenting author, including a valid email address.
Additional Authors:Enter all additional authors in the order they should appear in the program and abstract book. The abstract submission form will guide you through the process of entering the additional author(s).
Language:All abstracts must be in English
Abstract Body:The abstract text should be typed single-spaced and may not exceed 500 words (350 to 400 words is preferred).
Abstract Content:Abstracts must describe previously unpublished work. Abstracts previously published for other domestic or international meetings cannot be accepted.
Review: Preparation of the abstract should be rigorous and the abstract checked for errors and accuracy before submission. Errors in the submitted abstract cannot be corrected once the abstract is accepted. Errors can be corrected in the poster, so the whole set of data and information presented is accurate. Accepted abstracts will be printed in the abstract book as submitted and so care should be taken to ensure that abstracts are free of errors.
| Time | Speaker | Co-Chairs |
|---|---|---|
| 08:00 - 08:45 | Registration and breakfast | |
| 08:45 - 09:15 | Inauguration | Bharath S and Anandi Karumbati |
| 9:15-10:05 | Keynote 1: Dr. Ashok Venkitaraman, Distinguished Professor of Medicine, NUS, Chief Scientist, A-Star, Singapore | Anandi Karumbati |
| 10:05 - 10:40 | Dr. Raju Subramanian, Executive Director, Gilead Sciences, USA | Anandi Karumbatir |
| 10:40 - 10:55 | Group Photo | |
| 10:55 - 11:10 | Tea Break | |
| 11:10 - 11:30 | Sponsor talk (Eurofins) | Geetha T and Krishna Iyer |
| 11:30 - 11:50 | Sponsor talk - Krishgen | |
| 11:50 - 12:25 | Dr. Upendra Argikar, DMPK Leader, Gates Medical Research Institute, USA | |
| 13:00 - 15:30 | Lunch, Poster & Exhibitor Session | |
| 15:30 - 16:05 | Dr. Devang Shah, Director, Bristol Myers Squibb, Bangalore |
| 16:15 - 16:50 | Dr. Shridhar Narayanan, Founder Peptris/ FNDR, Banglaore | |
| 16:50 - 17:25 | Dr. Priyaranjan Pattanaik, Vice President, Syngene International Limited, Bangalore | |
| 17:25 - 18:00 | Dr. Ramanathan Sowdhamini , Senior Professor, National Center for Biological Sciences, Bangalore | |
| Session 3: Advancements in Understanding Solid state of Pharmaceuticals | ||
|---|---|---|
| 16:15 - 16:50 | Dr. Arvind K Bansal, Professor, Department of Pharmaceutics NIPER, Mohali | |
| 16:50 - 17:25 | Dr.Ramanaiah Chennuru, Director and Head, COE-Polymorphism and Crystallization, Cipla Ltd. | |
| 17:25 - 18:00 | Dr. Sharmistha Paldatta, Scientist & Lead, Solid State Screening Group, Dr. Reddy's Laboratories, Hyderabad | Continuation of Common Session |
| 18:10 - 19:30 | Cultural Program | |
| 19:30 - 20:30 | Networking and Dinner at Ramaiah University | |
| Time | Topic | Co-Chairs |
|---|---|---|
| 08:00 - 08:30 | Breakfast | |
| 08:30 - 09:20 | Keynote 2: Dr. Stephan Bromacher, Novartis | Dr. Hemant Bhutani |
| 09:20 - 09:55 | Dr Manojkumar Singh, Senior Vice President, Analytical Research and Development, Microlabs | |
| 09:55 - 10:30 | Dr. Sajesh Thomas, Associate Professor, IIT, Delhi | Dr. Lakshmikant Bajpai and Dr. Rajesh Gandhi |
| 10:30 - 11:05 | Dr. Sunil Kumar Panigrahi, Associate Vice President, Aurigene Pharmaceutical Services Ltd. | |
| 11:05 - 11:20 | Tea Break | |
| 11:20 - 11:40 | Sponsor talk - Corning | |
| 11:40 - 12:00 | Sponsor talk (Aragen) | Dr. Shashyendra Singh |
| 12:05 - 12:20 | Felicitation of sponsors | |
| 12:20 - 13:30 | Student talks (6 Talks) | Dr. Amol Raje and Dr. R. Deveswaran |
| 13:30 - 16:00 | Lunch, Poster & Exhibitor Session |
| 16:00 - 16:35 | Dr. Maloy Ghosh CSO, Zumutor Biologics | Prof. Rajkapoor B and Dr. Swaminathan Sethu |
| 16:35 - 17:10 | Dr. Arati Ramesh, Principal Scientist, Tata Institute of Genomics and Society | |
| 17:10 - 17:45 | Dr. Narmada B C , Lead Scientist, Vantage | |
| Session 6: Intricacies in the Development of Next Generation Therapeutics | ||
|---|---|---|
| 16:00 - 16:35 | Dr. Ravi Shah, Professor & Head, Department of Pharmaceutical Analysis, NIPER, Ahmedabad | Dr. Hetal Thakkar and Dr. J. Anbu |
| 16:35 - 17:10 | Dr. M. V. Narendra Kumar Talluri, Director, Daicel Chiral Technologies | |
| 17:10 - 17:45 | Dr. Manikandan R, Senior Vice President, Analytical Research and Development, Granules India | |
| Continuation of Common Session | ||
| 17: 45 -18:30 |
Panel Discussion. Fireside chat with Pathbreakers
|
Dr. T. Thanga Mariappan |
| Time | Topic | Co-Chairs |
|---|---|---|
| 08:00 - 08:30 | Breakfast |
| 08:30 - 09:05 | Dr. Hiroyuki Kusuhara, University of Tokyo, President of JSSX | Dr. Premkumar and Dr. Ashoka Babu V L |
| 09:05 - 09:40 | Dr. Rama Sivasubramanian, Head of R&D – India, Teva Pharmaceuticals | |
| 09:40 - 10:15 | Dr. Sahadev Shankarappa, Professor, Ramaiah University | |
| 10:15 -10:30 | Tea Break |
| 10:30 - 11:05 | Dr. Kumar Nemmani, Associate Vice President, Sun Pharma | Dr. Surulivel Rajan and Dr. Manasa Deepa |
| 11:05 - 11:40 | Mr. Prasad Chodavarupu, Founder and Managing Director, Aganitha Cognitive Sciences | |
| 11:40 - 12:15 | Dr. Vijay Kulkarni, Co-Founder & Director, Swalava Enterprises Private Ltd. | |
| 12:15 - 12:45 | Awards | Dr. Amol Raje and Dr. R. Deveswaranr |
| 12:45 - 13:00 | Vote of Thanks | Dr. Arti Thakkar |
| 13:00 - 14:00 | Lunch |
| SL. NO. | HOTEL | PRICE | ADDRESS | PHONE NO. | DISTANCE FROM MSRUAS |
|---|---|---|---|---|---|
| 1 | Hotel Mountain Paradise | ₹ 1,500.00 | No.12, Deepak Mansion, 2nd cross, MSREC Road, Mathikere, Bangalore 560054 | 08041303315 | 500 meters |
| 2 | Withinn Hotel | ₹ 1500 - ₹ 2500 | No.9A,12th main, 2nd Cross, MSR Nagar Mathikere Extn Bangalore 560054 | 8042037389 7760524738 |
500 meters |
| 3 | Hotel NestInn | ₹ 1350 - ₹ 1680 | #87/1,2nd Cross, MSR college road, Mathikere, Banglore-560054 | 8867769916 9980923192 |
500 meters |
| 4 | Dhaya Residency | ₹ 1200 | No.8/1,8/2,2nd Cross, MSRIT college road Mathikere, Bangalore- 560054 | 08041303315 | 500 meters |
| 5 | The Green Path Eco Hotel | ₹ 2560 - ₹ 3150 | New BEL Road, Seenappa Layout, Jaladarsini Layout, R.M.V. 2nd stage, Bengaluru | 9538887700 | 700 meters |
| 6 | NICE STAY | ₹ 2600 - ₹ 3200 | Palace Ground, IISc, 10, Suguna House, 1st Main, Between Mekhri Circle and Hebbal, &, CPRI Rd, near CBI Office, near Armane Nagar, HGH Layout, Ganganagar, Bengaluru, Karnataka 560032 | +91 91291 66099 | 4 km |
| 7 | UR Residency | ₹ 1250 - ₹2250 | Uma Complex, 13/A, New BEL Rd opp Maha Bazar, CM Halli, Devasandra Layout, Mathikere, Bengaluru, Karnataka 560054 | 9988776655 | 800 meters |
| 8 | Crimson Lotus | ₹ 2700 - ₹ 450 | MLA Layout, 60, 4th Main Rd, Dollars Colony, R.M.V. 2nd Stage, Bengaluru, Karnataka 560094 | 8917533352 | 1.3 KM |
| 9 | Prestige Stay Inn | ₹ 2400 - ₹2700 | No.11, 6th Main, Mathikere, Bangalore 560054 | 08012345678 | 300 meters |
| 10 | The Lavender Sing 65 | ₹ 3500 | No 438/C, Gokul 1Stage, HMT Main Road, Mathikere, Bengalore-560054 | 9071236565 | 1 km |
Distinguished Professor of Medicine, NUS, Chief Scientist, A-STAR, Singapore
NA
Executive Director, Gilead Sciences
Innovative Approaches for DMPK Problems in Drug Discovery: Assessment of Hydrogen/Deuterium Exchange for In Vitro Chiral Stability of Pharmacophores and Use of Encequidar to Delineate In Vivo Disposition Pathways
DMPK Leader, Gates Medical Research Institute
DMPK insights in the development of sutezolid, a mycobacterium tuberculosis inhibitor
Director, Bristol Myers Squibb, Bangalore
NA
Founder, Peptris/FNDR
Engineering the Future Drugs-Innovating in India for the World
Vice President, Syngene International Limited
NA
Senior Professor, National Center for Biological Sciences
Recognition of small molecule inhibitors for TOLL-like receptor 4 through integrated approaches
Professor, Department of Pharmaceutics, NIPER
Crystal Structure–Guided Insights into Milling Behavior of Pharmaceutical Solids
Director and Head, COE-Polymorphism and Crystallization, Cipla
Solid-State Strategies in Generic Pharmaceuticals: From Polymorphs to Cocrystals
Scientist & Lead, Solid State Screening Group, Dr. Reddy's
Advancements in understanding of solid state of Pharmaceuticals
Senior Scientist, Novartis
Necessity is the Mother of Invention: the challenges of novel pharmaceutical entities and the analytics they inspire
Senior Vice President, Analytical Research and Development, Microlabs
A QBD approach of Analytical method development
Associate Professor, IIT, Delhi
NA
Associate Vice President, Aurigene Pharmaceutical Services Ltd.
NA
CSO, Zumutor Biologics
From High-Diversity Human Ig Libraries to Developable IgGs: A Parallel Selection and Optimization Strategy
Principal Scientist, Tata Institute of Genomics and Society
Re-imagining antimicrobials: Antisense oligomer-based therapeutics against infectious disease
Lead Scientist, Vantage
Metabolize this! A QSP story in the fight against Obesity and Diabetes
Senior Vice President, Analytical Research and Development, Granules India
Challenges in Chemistry, Manufacturing, and Controls (CMC) for NextGeneration Therapeutics
Professor & Head, Department of Pharmaceutical Analysis, NIPER
Professor & Head, Department of Pharmaceutical Analysis, NIPER
Director, Daicel Chiral Technologies
NA
University of Tokyo, President of JSSX
Application of Intestinal Stem Cell–Derived In Vitro Models for ADME and Toxicity Assessment in Drug Development
Head of R&D, Teva Pharmaceuticals
Emerging Trends in Drug–Drug Interaction Evaluation: From Mechanistic Models to AI-Driven Predictions
Professor, Ramaiah University
Designing Nanoparticles to Navigate Axonal Routes for Targeted Neural Drug Delivery
Associate Vice President, Sun Pharma
Integrating DMPK Principles to Engineer Next-Generation Antibody–Drug Conjugate Immunotherapies for Cancer
Founder and Managing Director, Aganitha Cognitive Sciences
Lessons from a year of applying Agentic AI in Biopharma R&D
Co-Founder & Director, Swalava Enterprises Private Ltd.
NA
Distinguished Professor of Medicine, NUS, Chief Scientist, A-STAR, Singapore
Executive Director, Gilead Sciences
DMPK Leader, Gates Medical Research Institute
Director, Bristol Myers Squibb, Bangalore
Founder, Peptris/FNDR
Vice President, Syngene International Limited
Senior Professor, National Center for Biological Sciences
Professor, Department of Pharmaceutics, NIPER
Director and Head, COE-Polymorphism and Crystallization, Cipla
Scientist & Lead, Solid State Screening Group, Dr. Reddy's
Senior Scientist, Novartis
Senior Vice President, Analytical Research and Development, Microlabs
Associate Professor, IIT, Delhi
Associate Vice President, Aurigene Pharmaceutical Services Ltd.
CSO, Zumutor Biologics
Principal Scientist, Tata Institute of Genomics and Society
Lead Scientist, Vantage
Senior Vice President, Analytical Research and Development, Granules India
Professor & Head, Department of Pharmaceutical Analysis, NIPER
Director, Daicel Chiral Technologies
University of Tokyo, President of JSSX
Head of R&D, Teva Pharmaceuticals
Professor, Ramaiah University
Associate Vice President, Sun Pharma
Founder and Managing Director, Aganitha Cognitive Sciences
Co-Founder & Director, Swalava Enterprises Private Ltd.